Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P01178 (oxytocin)
 15,767 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

14 nulliparas and 28 multiparas were induced at term by combined low amniotomy and oral prostaglandin E2 (PGE2) solution. Doses, after a .5 mg test dose, were 1, 1.5, or 2.0 mg at 2-hour intervals. There were 37 successful deliveries, 3 Caesarean sections, and 2 failures, later successful with oxytocin. Induction delivery intervals averaged 12.6 hours in nulliparas and 8.9 hours in multiparas, and were inversely proportional to pelvic score. Fetal distress occurred in 2 cases. No other fetal side effects were reported, but vomiting was frequent (28.5%) and sometimes severe.
 ...
PMID:Experiences with oral prostaglandin E2 and amniotomy in the induction of labour. 90 16

Between 1975 and 1985 from 522 patients, who had undergone caesarean section during their previous delivery or deliveries, per cent 63 have been delivered vaginally and 37 per cent with a caesarean section (52.8% primary, 47.2% secondary). The rate of spontaneous labour was higher, if patient had a spontaneous delivery before caesarean section or the first caesarean section has been performed because of a placenta praevia, a breech presentation or a fetal distress syndrome. Cephalopelvic disproportion went on in 67.2 per cent with a caesarean section. Rupture of the scare occurred in 2.9 per cent. Expectative management of delivery is justified following previous caesarean section. Oxytocin infusions are possible in cases if internal tocography will be done.
 ...
PMID:[Once cesarean section--always cesarean section?]. 321 12

The outcome of labor induced by use of a glyceride-based vaginal suppository of prostaglandin E2 (PGE2) inserted 3 hours before amniotomy, when the cervix is favorable, has been assessed. Using 5 mg PGE2 for primigravidas and 2.5 mg for multigravidas, 63% of the former and 81% of the latter established labor and were delivered of their infants without oxytocin augmentation, allowing ambulation during early labor. No maternal complications were detected as a result of the PGE2 treatment. Compared with patients undergoing conventional induction by amniotomy and immediate oxytocin titration there was no difference in the duration of labor, with a few patients establishing labor and giving birth quickly with both induction methods. Fetal distress was less common following PGE2 treatment than following conventional induction, with three patients in each group requiring delivery by cesarean section. Cephalopelvis disproportion in the second stage of labor requiring cesarean section to deliver occurred more frequently in the prostaglandin-treated group, possibly as a result of reduced upper segment contractility in the first stage of labor with subsequent poor fetal head molding. Epidural analgesia and postpartum hemorrhge were both reduced following PGE2-induced labor.
 ...
PMID:A simpler approach to labor induction using lipid-based prostaglandin E2 vaginal suppository. 694 46

A double-blind clinical trial was conducted to determine if misoprostol (exogenous prostaglandin E1 PGE1) used vaginally was of value in improving the Bishop score, leading to an early safe vaginal delivery in women in whom the cervix is unripe and delivery is indicated. 45 women were selected from the antenatal ward and clinic of the University Hospital of the West Indies. All were women in the 3rd trimester of pregnancy who had an indication for induction, an unripe cervix, and no contraindication to prostaglandins. The women were randomly assigned to receive treatment or a placebo. The treated group had 100 mcg misoprostol inserted vaginally, while the placebo was similarly inserted. Efficacy of the misoprostol was measured by the increase in the Bishop score 12 hours after giving the treatment, the time between insertion and delivery, the need for oxytocin, and the outcome of the pregnancy. The prostaglandin was superior to the placebo in ripening the cervix and inducing labor. The change in Bishop score was 5.3 in the misoprostol group compared with 1.5 in the placebo group (P0.001). 8% of patients had no change in their Bishop score in the misoprostol group compared to 62% in the placebo group (P0.001). The mean time from insertion to delivery was 15.6 hours in the former while it was 43.2 hours in the placebo group (P=0.001). 29% of women receiving misoprostol needed oxytocin compared with 62% of those who received the placebo (P0.02). There was no difference in the 2 groups in the delivery outcome in terms of complications, Apgar scores, and mode of delivery. There were no significant changes in maternal vital signs in both groups. Fetal distress, as evidenced by the presence of meconium stained amniotic fluid or fetal tachycardia, was similar in both groups. Polystole (more than 5 contractions in 10 minutes occurred in 1 woman in the misoprostol group. Extra-amniotic misoprostol is a cheap, effective, and safe prostaglandin for cervical ripening.
 ...
PMID:Intravaginal misoprostol as a cervical ripening agent. 836 46